327 related articles for article (PubMed ID: 33068774)
21. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
22. Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury.
Ding Y; Li Y; Zhang X; He J; Lu D; Fang X; Wang Y; Wang J; Zhang Y; Qiao X; Gan LM; Chen C; Zhu Y
J Mol Cell Cardiol; 2017 Sep; 110():70-79. PubMed ID: 28736260
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice.
Liu Y; Dang H; Li D; Pang W; Hammock BD; Zhu Y
PLoS One; 2012; 7(6):e39165. PubMed ID: 22720061
[TBL] [Abstract][Full Text] [Related]
24. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
[TBL] [Abstract][Full Text] [Related]
25. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
26. Sirtuin 6 ameliorates alcohol-induced liver injury by reducing endoplasmic reticulum stress in mice.
Xin Y; Xu L; Zhang X; Yang C; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Mar; 544():44-51. PubMed ID: 33516881
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
28. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349
[TBL] [Abstract][Full Text] [Related]
29. Hepatic protein tyrosine phosphatase Shp2 disruption mitigates the adverse effects of ethanol in the liver by modulating oxidative stress and ERK signaling.
Hsu MF; LeBleu G; Flores L; Parkhurst A; Nagy LE; Haj FG
Life Sci; 2024 Mar; 340():122451. PubMed ID: 38253311
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice.
Inceoglu AB; Clifton HL; Yang J; Hegedus C; Hammock BD; Schaefer S
J Cardiovasc Pharmacol; 2012 Jul; 60(1):70-5. PubMed ID: 22526297
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK.
Luo Y; Wu MY; Deng BQ; Huang J; Hwang SH; Li MY; Zhou CY; Zhang QY; Yu HB; Zhao DK; Zhang G; Qin L; Peng A; Hammock BD; Liu JY
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5154-5159. PubMed ID: 30804206
[TBL] [Abstract][Full Text] [Related]
32. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
33. Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.
Edin ML; Gruzdev A; Graves JP; Lih FB; Morisseau C; Ward JM; Hammock BD; Bosio CM; Zeldin DC
FASEB J; 2024 May; 38(10):e23692. PubMed ID: 38786655
[TBL] [Abstract][Full Text] [Related]
34. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
[TBL] [Abstract][Full Text] [Related]
35. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
36. Soluble epoxide hydrolase deficiency promotes liver regeneration and ameliorates liver injury in mice by regulating angiocrine factors and angiogenesis.
Deng W; Hu T; Xiong W; Jiang X; Cao Y; Li Z; Jiang H; Wang X
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130394. PubMed ID: 37315719
[TBL] [Abstract][Full Text] [Related]
37. Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.
Ma M; Ren Q; Yang J; Zhang K; Xiong Z; Ishima T; Pu Y; Hwang SH; Toyoshima M; Iwayama Y; Hisano Y; Yoshikawa T; Hammock BD; Hashimoto K
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7083-7088. PubMed ID: 30890645
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
39. Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury.
Liu LP; Li B; Shuai TK; Zhu L; Li YM
BMC Anesthesiol; 2018 Apr; 18(1):48. PubMed ID: 29703148
[TBL] [Abstract][Full Text] [Related]
40. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.
Ramirez T; Li YM; Yin S; Xu MJ; Feng D; Zhou Z; Zang M; Mukhopadhyay P; Varga ZV; Pacher P; Gao B; Wang H
J Hepatol; 2017 Mar; 66(3):601-609. PubMed ID: 27871879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]